Enhancing Fairness in AI/ML Models for Healthcare Using Real-World Data

By Charmi Patel

May 22, 2024

Introduction

The latest research in artificial intelligence (AI) and machine learning (ML) has completely transformed healthcare industry, providing solutions for risk prediction, disease diagnosis, and outcome forecasting. The integration of AI/ML with real-world data (RWD) has shown promise in improving healthcare decision-making processes. However, concerns about algorithmic bias and fairness have emerged, emphasising the need for comprehensive research in this area.

Understanding Algorithmic Bias in Healthcare

Algorithmic fairness in AI/ML applications is crucial to prevent biases that could disproportionately impact different societal groups. Furthermore, examples from healthcare, such as biassed health cost predictions and disparities in disease outcomes, underscore the importance of fair AI/ML practices in healthcare settings.

Assessing Fairness in AI/ML Models

Researchers use metrics such as equality of opportunity, predictive parity, and statistical parity to assess fairness in ML models. Subsequently, they commonly apply pre-processing techniques like reweighing and data imputation to mitigate bias and improve fairness in healthcare applications.

Mitigating Bias in Healthcare AI/ML

Studies have explored pre-processing, in-processing, and post-processing methods to address bias in ML models. Furthermore, techniques such as recalibration and reweighing have shown promise in improving fairness and reducing disparities in healthcare predictions.

Future Research and Recommendations

Future research should focus on expanding fair ML practices into multi-modality and unstructured data. Consequently, this enhances model interpretability, addressing biases in data collection and governance. Collaborative efforts among AI experts, healthcare professionals, and ethicists are essential to ensure the ethical and equitable use of AI/ML in healthcare settings.

Advancing fair AI/ML practices in healthcare with RWD highlights the need for ongoing research. This promotes trustworthy and inclusive healthcare decision-making processes. Continuous exploration in this field is crucial. Lastly, it highlights the critical nature of ongoing investigations in advancing healthcare AI/ML practices.

The Role of Explainable AI in Healthcare

Explainable AI plays a vital role in healthcare by providing transparency and interpretability in AI/ML models, aiding in understanding how decisions are made and increasing trust in the technology.

Reference url

Recent Posts

semaglutide NAION risk
    

Semaglutide NAION Risk: EMA Review Initiated Amid Conflicting Evidence

🔍 Is semaglutide linked to vision loss?

The European Medicines Agency’s PRAC is currently reviewing the potential risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with semaglutide-containing medicines, including popular treatments like Ozempic and Wegovy. With recent studies yielding conflicting evidence, this review is crucial for patient safety and the future of these therapies.

Read the full article to understand the implications and what this could mean for healthcare providers and patients alike!

#SyenzaNews #Pharmaceuticals #HealthcarePolicy

cervical cancer screening
        

Cost-Effective Cervical Cancer Screening Strategies for Women with HIV in KwaZulu-Natal

💡 *Are single-visit cervical cancer screenings the key to better health outcomes in high HIV prevalence areas?*
A recent study from KwaZulu-Natal, South Africa reveals that repeat single-visit cervical cancer screening using HPV DNA testing is not only the most effective but also the most cost-effective approach for women living with HIV. This aligns with WHO recommendations for comprehensive cervical cancer elimination strategies.

Explore the insights and implications of this vital research that could transform cervical cancer prevention in resource-limited settings.

#SyenzaNews #HealthEconomics #oncology #GlobalHealth

EU Health Technology Assessment
          

Advancing EU Health Technology Assessment: Insights from the HAG Meeting

💡 How can the EU Health Technology Assessment reshape healthcare delivery?

The recent meeting of the Heads of HTA Agencies Group heralds a new era with the operationalization of the EU’s Health Technology Assessment Regulation, aiming to streamline processes and enhance collaboration across member states.

This initiative promises to improve data transparency, foster innovative health technologies, and ultimately, drive better patient outcomes.

Curious to learn more about these significant updates and what they mean for the future of health assessments in the EU? Jump into the full article!

#SyenzaNews #HealthTech #HealthEconomics #DigitalTransformation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.